徐雅莉;曹希;孙强;

• 1:中国医学科学院北京协和医学院北京协和医院乳腺外科

摘要(Abstract)：

<正>近年来随着生活水平和早期诊断水平的提高,乳腺癌发病率呈上升趋势,位居女性恶性肿瘤首位。因此,乳腺癌危险因素受到广泛关注,其中初潮年龄早、绝经年龄晚延长雌激素暴露时间,明确增加了Luminal型乳腺癌的发病风险~([1-2])。血脂代谢是卵巢外雌激素合成的主要途径,因此高脂血症与乳腺癌发病风险的关系引起了广泛关注~([3-4])。早期诊断和治疗水平的提高使乳腺癌人群不

关键词(KeyWords)： 高脂血症;乳腺癌;高胆固醇血症;27-羟胆固醇

Abstract:

Keywords:

基金项目(Foundation): 国家科技支撑计划(2014BAI08B03)

作者(Author): 徐雅莉;曹希;孙强;

Email:

DOI:

参考文献(References)：

• [1]Petracci E,Decarli A,Schairer C,et al.Risk factor modification and projections of absolute breast cancer risk[J].J Natl Cancer Inst,2011,103:1037-1048.
• [2]Sisti JS,Collins LC,Beck AH,et al.Reproductive risk factors in relation to molecular subtypes of breast cancer:Results from the nurses'health studies[J].Int J Cancer,2016,138:2346-2356.
• [3]Bianchini F,Kaaks R,Vainio H.Overweight,obesity,and cancer risk[J].Lancet Oncol,2002,3:565-574.
• [4]Capasso I,Esposito E,Pentimalli F,et al.Metabolic syndrome affects breast cancer risk in postmenopausal women:National Cancer Institute of Naples experience[J].Cancer Biol Ther,2010,10:1240-1243.
• [5]Hua X,Wu J,Goldstein JL,et al.Structure of the human gene encoding sterol regulatory element binding protein-1(SREBF1)and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13[J].Genomics,1995,25:667-673.
• [6]Zelcer N,Hong C,Boyadjian R,et al.LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor[J].Science,2009,325:100-104.
• [7]Zhang L,Reue K,Fong LG,et al.Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis[J].Arterioscler Thromb Vasc Biol,2012,32:2541-2546.
• [8]Karuna R,Holleboom AG,Motazacker MM,et al.Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism[J].Atherosclerosis,2011,214:448-455.
• [9]Vrieling A,Buck K,Kaaks R,et al.Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status:a meta-analysis[J].Breast Cancer Res Treat,2010,123:641-649.
• [10]Renehan AG,Roberts DL,Dive C.Obesity and cancer:pathophysiological and biological mechanisms[J].Arch Physiol Biochem,2008,114:71-83.
• [11]Gunter MJ,Xie X,Xue X,et al.Breast cancer risk in metabolically healthy but overweight postmenopausal women[J].Cancer Res,2015,75:270-274.
• [12]Hu J,La Vecchia C,de Groh M,et al.Dietary cholesterol intake and cancer[J].Ann Oncol,2012,23:491-500.
• [13]Ronco AL,De Stefani E,Stoll M.Hormonal and metabolic modulation through nutrition:towards a primary prevention of breast cancer[J].Breast,2010,19:322-332.
• [14]Must A,Spadano J,Coakley EH,et al.The disease burden associated with overweight and obesity[J].JAMA,1999,282:1523-529.
• [15]Howard BV,Ruotolo G,Robbins DC.Obesity and dyslipidemia[J].Endocrinol Metab Clin North Am,2003,32:855-867.
• [16]Nelson ER,Wardell SE,Jasper JS,et al.27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology[J].Science,2013,342:1094-1098.
• [17]Pfefferle AD,Herschkowitz JI,Usary J,et al.Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts[J].Genome Biol,2013,14:R125.
• [18]Llaverias G,Danilo C,Mercier I,et al.Role of cholesterol in the development and progression of breast cancer[J].Am J Pathol,2011,178:402-412.
• [19]Undela K,Srikanth V,Bansal D.Statin use and risk of breast cancer:a meta-analysis of observational studies[J].Breast Cancer Res Treat,2012,135:261-269.
• [20]Danilo C,Frank PG.Cholesterol and breast cancer development[J].Curr Opin Pharmacol,2012,12:677-682.
• [21]Printz C.Researchers find link between high cholesterol and breast cancer[J].Cancer,2014,120:3429.
• [22]Kitahara CM,Berrington de Gonzalez A,Freedman ND,et al.Total cholesterol and cancer risk in a large prospective study in Korea[J].J Clin Oncol,2011,29:1592-1598.
• [23]Allott EH,Hursting SD.Obesity and cancer:mechanistic insights from transdisciplinary studies[J].Endocr Relat Cancer,2015,22:R365-R386.
• [24]Bensinger SJ,Bradley MN,Joseph SB,et al.LXR signaling couples sterol metabolism to proliferation in the acquired immune response[J].Cell,2008,134:97-111.
• [25]Alikhani N,Ferguson RD,Novosyadlyy R,et al.Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model[J].Oncogene,2013,32:961-967.
• [26]Du Sell CD,Mc Donnell DP.27-Hydroxycholesterol:a potential endogenous regulator of estrogen receptor signaling[J].Trends Pharmacol Sci,2008,29:510-514.
• [27]Du Sell CD,Umetani M,Shaul PW,et al.27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator[J].Mol Endocrinol,2008,22:65-77.
• [28]Nelson ER,Du Sell CD,Wang X,et al.The oxysterol,27-hydroxycholesterol,links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors[J].Endocrinology,2011,152:4691-4705.
• [29]Fu X,Menke JG,Chen Y,et al.27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells[J].J Biol Chem,2001,276:38378-38387.
• [30]Corsini A,Maggi FM,Catapano AL.Pharmacology of competitive inhibitors of HMG-Co A reductase[J].Pharmacol Res,1995,31:9-27.
• [31]Vini R,Juberiya AM,Sreeja S.Evidence of pomegranate methanolic extract in antagonizing the endogenous SERM,27-hydroxycholesterol[J].IUBMB Life,2016,68:116-121.
• [32]Hansson M,Ellis E,Hunt MC,et al.Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages[J].Biochim Biophys Acta,2003,1593:283-289.
• [33]Sica A,Larghi P,Mancino A,et al.Macrophage polarization in tumour progression[J].Semin Cancer Biol,2008,18:349-355.
• [34]Wu Q,Ishikawa T,Sirianni R,et al.27-Hydroxycholesterol promotes cell-autonomous,ER-positive breast cancer growth[J].Cell Rep,2013,5:637-645.
• [35]Bahl M,Ennis M,Tannock IF,et al.Serum lipids and outcome of early-stage breast cancer:results of a prospective cohort study[J].Breast Cancer Res Treat,2005,94:135-144.
• [36]Jiralerspong S,Kim ES,Dong W,et al.Obesity,diabetes,and survival outcomes in a large cohort of early-stage breast cancer patients[J].Ann Oncol,2013,24:2506-2514.
• [37]Ahern TP,Pedersen L,Tarp M,et al.Statin prescriptions and breast cancer recurrence risk:a Danish nationwide prospective cohort study[J].J Natl Cancer Inst,2011,103:1461-1468.
• [38]Kwan ML,Habel LA,Flick ED,et al.Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors[J].Breast Cancer Res Treat,2008,109:573-579.
• [39]Nielsen SF,Nordestgaard BG,Bojesen SE.Statin use and reduced cancer-related mortality[J].N Engl J Med,2012,367:1792-1802.
• [40]Raccosta L,Fontana R,Maggioni D,et al.The oxysterolCXCR2 axis plays a key role in the recruitment of tumorpromoting neutrophils[J].J Exp Med,2013,210:1711-1728.
• [41]Kaiser J.Cholesterol forges link between obesity and breast cancer[J].Science,2013,342:1028.
• [42]Laisupasin P,Thompat W,Sukarayodhin S,et al.Comparison of serum lipid profiles between normal controls and breast cancer patients[J].J Lab Physicians,2013,5:38-41.
• [43]Lee WR,Ishikawa T,Umetani M.The interaction between metabolism,cancer and cardiovascular disease,connected by27-hydroxycholesterol[J].Clin Lipidol,2014,9:617-624.